News

Oct

Spreading Holiday Cheer

CFFC's core mission is to support the local CF community. That means emotional support as well as financial support. With the COVID protocols, people living with CF may feel even more isolated than usual. CFFC wants to help relieve some of those feelings by offering to deliver a holiday wreath or a poinsettia plant to the home of someone living with CF. We want to add a bit of holiday cheer to the household as well as let them know we care about their well being. Check out the details below. Feel free to pass this message along to others who may be interested. You can share this announcement: Holiday Ad 2020 We will provide the wreath or poinsettia at no cost. However, if you want to add a personal touch by sponsoring the gift contact CFFC president Karly Schuhart at KSchuhart03@gmail.com. While we care for everyone living with CF, this offer is limited to individuals served by the Rochester CF center.

Oct

Clinical Trial Alerts – October 2020

Cystic Fibrosis Foundation issued the following clinical trial alerts in October. October 15, 2020 Study of VX-445 triple combination in children 6-11 years old with cystic fibrosis Status: Completed with Results Description: This study evaluated the safety and effectiveness of the triple combination modulator therapy, elexacaftor/tezacaftor/ivacaftor (Trikafta®) in children ages 6-11 years with CF, who have either two copies of the F508del mutation or one copy of the F508del mutation and one minimal function mutation. Age: 6 Years to 11 Years Mutation: Two Copies F508del or One Copy F508del Fev1% Predicted: 40% or greater Number of Visits: 9 Length of Participation: 32 weeks ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT03691779 Study to evaluate inhaled molgramostim in adults 18 years and older with cystic fibrosis and an NTM infection in the lungs Status: Completed with Results Description: This study evaluated the effectiveness of inhaled molgramostim (Molgradex), a drug intended to treat nontuberculous mycobacterial (NTM) infections in the lungs of people with CF. Age: 18 Years and Older Mutation: No Mutation Requirement Fev1% Predicted: 30% or greater Number of Visits: 19 Length of Participation: 72 weeks ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT03597347

Oct

CFFC Facebook Posts – October 2020 – Part 1

10/01/2020 - What Are Your Remaining Medical Needs Post-Trikafta? - Gunnar Esiason gives us reality check in the euphoria associated with the success of CFTR modulators. And he is asking for some information to help him describe the post-Trikafta CF world. 10/02/2020 - Oral antibiotics torpedo Pseudomonas as effectively as IVs – The study cited in this article dealt with the initial Pseudomonas infection. 10/03/2020 - Potential Gene Therapy, SPIRO-2101, Named Rare Pediatric and Orphan Disease by FDA – Further evidence that researchers are not abandoning those in the CF community who cannot benefit from CFTR modulators. 10/04/2020 - Raising an Adult (in Training) – Learning to manage your own care starts at an early age. 10/05/2020 - Study: Screening for Hearing Loss in CF Patients Feasible With Tablet-based Tests – Hearing loss can be a side effect of antibiotic treatments. This study suggests a path to earlier detection. 10/06/2020 - Disability is a Reinvestment, Not a Defeat – The power of a word; the unfortunate power of a misunderstood word. This blog may help you combat misplaced ableism. 10/07/2020 - Drink coffee after breakfast, not before, for better metabolic control – CF-related diabetes is a significant issue in the CF community. This study indicates that those with CFRD may want to consider the timing of your morning coffee. 10/08/2020- Research in focus: Antimicrobial resistance in cystic fibrosis – The report linked in this article describes the efforts funded by Cystic Fibrosis Trust (the UK equivalent of Cystic Fibrosis Foundation) to overcome resistant infections. 10/10/2020 - How Do You Decide What Is Worth the Risk of COVID-19? - This blogger shares her approach to re-entering the world in the era of COVID. She even included a decision tree. 10/11/2020 - Lenabasum Fails to Lessen Exacerbations in CF Patients in Phase 2 Trial – It is important to understand that not all potential treatment are successful. 10/12/2020 - Despite the Detours, I Live a Full ...

Sep

CFFC Facebook Posts – September 2020 – Part 2

09/16/2020 - Researchers discover a specific brain circuit damaged by social isolation during childhood – While this article is geared toward the isolation associated with the COVID-19 response, you can probably see the connection to the isolation that may be experienced by children with CF. 09/17/2020 - Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data – This development is profound. Imagine mitigating infections before lung tissue is damaged. 09/18/2020 - My Return to In-Person Clinic Visits – If you have had an in-person clinic visit recently, you can compare your experience. If not, this blog gives you a peek at what to expect. 09/19/2020 - With CF Clinics Reopening, 10 Tips for a Productive Visit – Unlike yesterday's post, Gunnar Esiason's reflection on his first “inside” clinic visit post-pandemic are recommendations that apply to every clinic visit. 09/20/2020 - Next-gen organoids grow and function like real tissues – Advances in methodology have allowed researchers to grow more realistic organ tissue from stem cells. This, in turn, will produce better models for drug testing – and maybe transplantation. 09/21/2020 - Have Our Backs and Push Against Ableism With Us – The general population may be unaware that people with “invisible” disabilities are susceptible to discrimination. 09/22/2020 - Having a Newborn With CF During COVID-19 – While the circumstances are not common (thankfully), the reaction to the CF diagnosis is all to familiar. 09/23/2020 - Money and budgeting at university – former students share their tips – While some of these recommendations are specific to the UK, these students have some tips you may find helpful – in or out of college. 09/24/2020 - Moderna, Vertex Team Up to Develop Gene-editing Delivery Techniques – Not only does this research open new options for treating CF, it is also an important step in serving the CF population with mutations that do not benefit from CFTR modulators. 09/25/2020 - Why I Chose to Go Back to School in Person – ...

Sep

Clinical Trial Alerts – September 2020

Cystic Fibrosis Foundation issued the following clinical trial alerts in the month of September. September 8, 2020 Study to evaluate the effects of CFTR modulators in infants and young children (BEGIN Part A) Status: Enrolling Description: This two-part observational study will look at the effects of CFTR modulators on growth in young children with CF. These drugs are intended to help CFTR protein function closer to normal. Age: 0 Years to 4 Years Mutation: No Mutation Requirement Fev1% Predicted: No FEV1 Limit Number of Visits: 6 Length of Participation: 3 years ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT04509050 Study to evaluate the effects of CFTR modulators in infants and young children (BEGIN Part B) Status: Enrolling Description: This two-part observational study will look at the effects of CFTR modulators on growth in young children with CF. These drugs are intended to help CFTR protein function closer to normal. Age: Less than 6 Years Mutation: No Mutation Requirement Fev1% Predicted: No FEV1 Limit Number of Visits: 6 Length of Participation: 2 years ClinicalTrials.gov link: https://www.clinicaltrials.gov/ct2/show/NCT04509050 September 30, 2020 Study of VX-445 Triple Combination in Teens and Adults With Cystic Fibrosis (CF) Who Have One Copy of F508del and One Copy of a Gating or Residual Function Mutation Status: Completed with results Description: This study evaluated the safety and effectiveness of VX-445 (elexacaftor), tezacaftor, and ivacaftor in combination called TRIKAFTA®. This study was for people with CF 12 years and older with one copy of the F508del mutation and one copy of a gating or residual function mutation. Age: 12 Years and Older Mutation: One Copy F508del Fev1% Predicted: 40 to 90% Number of Visits: 8 Length of Participation: 20 weeks ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT04058353

Sep

Pain and Symptom Management Survey

Cystic Fibrosis Foundation is seeking input on issues relating to pain ans symptom management. Here is their announcement. In preparation for the upcoming Palliative Care: Pain and Symptom Management Guidelines, sponsored by the CF Foundation and chaired by two researchers, one from the University of North Carolina and one from Emory University, a survey has been developed to help us better understand the pain and symptom management needs of individuals with CF. We are asking adults with CF, caregivers of individuals with CF, and CF care team members to respond to participate in this anonymous survey. The results of this research study will be used to help us develop guidelines to improve pain and symptom management for people with CF. To help inform the scope of these guidelines and participate in this 10-15 minute survey, please click on the link below by Thursday, October 15th. Take Survey Please note that your identity will not be linked to your response as identifying information will not be collected during the survey. You will be asked about your experience with and practice patterns around pain and symptom management, and you may choose not to answer any or all questions. Completion of the survey implies your consent for participation in this research study.  Please contact communityvoice@cff.org if you have any questions, and please feel free to share this opportunity with others in the CF community that might be interested by using the buttons found at the bottom of this email. Many thanks for your time and your contributions to the care of individuals with CF! Best Regards,Elisabeth Dellon MD, MPHProfessor; Medical Director, Children’s Supportive Care Team; Director, UNC Cystic Fibrosis CenterDivision of PulmonologyDepartment of PediatricsUniversity of North CarolinaDio Kavalieratos, Ph.D.Associate Professor & Director of Research and QualityDivision of Palliative MedicineDepartment of Family and Preventive MedicineEmory University Sarah Hempstead, MSPractice Guidelines ManagerClinical AffairsCystic Fibrosis Foundation

Sep

Vote Safely in 2020

In recognition of the policy issues that may have a significant impact on the CF community, Cystic Fibrosis Foundation is offering information on those issues as well as guidance avoiding health risks while exercising your right to vote. Their announcement, including useful links, follows. Exercising your right to vote is an important way to advocate for people with cystic fibrosis. While participating in the 2020 General Election may look different this year due to COVID-19, you can follow these simple steps to stay safe while making your voice heard:  Make sure you are registered to vote Learn your state’s processes and deadlines for safe voting, including options to vote by mail LEARN MORE ABOUT HEALTHY VOTING Before you cast your ballot, familiarize yourself with the issues that matter to the CF community, including: Safeguarding protections for people with pre-existing conditions Maintaining strong funding for groundbreaking research and drug development Extending paid family and medical leave to high-risk individuals during COVID-19 Broadening access to telehealth services It's important to ask questions of candidates to understand how their positions would impact the CF community. SEE THE ISSUES THAT MATTER Regardless of the election’s outcome, the CF Foundation will continue to advocate tirelessly with and for the CF community until CF stands for Cure Found.  

Sep

CF Foundation October Events

Cystic Fibrosis Foundation is sponsoring several events in October. The Western New York Chapter provided the following details. Each event is also listed on the CFFC calendar. Oct 2, all day: ROSE UP ROSE UP is a virtual fundraising event created and led by adults with cystic fibrosis to bring the CF community together and ROSE UP for a cure. Our goal is to have 650 people from all 50 states register to ROSE UP with us to help us get one step closer to our collective dream - a cure for all people with CF. To learn more, visit: https://events.cff.org/ROSEUP Oct. 3, 10am: Great Strides Virtual Celebration Western NY/Rochester Chapter’s celebration of our virtual Great Strides efforts in 2020.  A Facebook Live event, join by visiting the CFF-WNY Facebook page. Oct. 6, 7pm: Together Now, A 65 Roses Challenge Celebration Registration is open for Together: Now!  On Tuesday, October 6 at 7 p.m. ET (4 p.m. PT), members of the CF community and legendary athletes will share their inspiring stories, and we will celebrate the many ways people with CF and their loved ones have tackled the 65 Roses Challenge to help us advance our mission To register, visit: https://community.cff.org/vlc/ October 14, 7pm: CFF Cares CF Foundation Cares is a casual gathering where those who are caring for people with cystic fibrosis can find support by connecting with fellow members of the CF community. The agenda for this virtual conversation is to share thoughts and experiences around school-age children and returning to school.  How are families adapting to the new year?  Are there questions that might be answered by other CF parents/caregivers?   Are there lessons learned or observations to share? CFF Cares is not a counseling session.  It is a place to have candid conversations, make lasting friendships, and discover new ways to navigate the CF journey. It is a place of encouragement and hope. To register: https://engage.cff.org/WNY-Rochester October 21-23: NACFC The North American Cystic Fibrosis Conference provides a collaborative and educational forum for all CF professionals.  The educational elements of the meeting program are targeted ...

Sep

CFFC Facebook Posts – September 2020 – Part 1

09/01/2020 - Preventing infection, facilitating healing: New biomaterials from spider silk – Science is a fascinating thing; especially when benefits come from unusual sources. [BTW: Think twice before you kill a spider.] 09/02/2020 - Transplant Anniversaries Acknowledge Trauma and Triumph – Transplantation affects your emotional well-being as well as your physical well being. 09/03/2020 - Two Years Ago This Week, I Decided My Life Needed to Change – Gunnar Esiason's story suggests that this time of disruption may be an opportunity to consider where you go from here. 09/04/2020 - Choosing Kindness Over Anger – This blogger tells us that attitude matters. 09/05/2020 - Vertex Seeks to Expand FDA Approval of CFTR Modulators to Include More Mutations - Extending the the approved use of existing CFTR modulators to more mutations is consistent with the “no one left behind” strategy for CF treatments. 09/06/2020 - New Technology Could Improve Detection of Biomarkers for CF, Other Diseases – CF research has benefited from findings relating to other diseases. This article points to a situation where Findings intended for CF may benefit research on COVID19. 09/07/2020 - Research survey for rare disease patients and their families about impacts of COVID-19 – Research funded by NIH is seeking to document the impact COVID-19 is having on individuals with rare disease (which includes CF). 09/08/2020 - CF Prepared Me for Isolation, But Not Homeschooling – As schools reopen in NY, this blog may resonate with you. 09/09/2020 - Exploiting the weak spots in M abscessus to design new antibiotics – This article describes an exciting development in the battle against resistant bacteria. 09/10/2020 - Emergency Fund – CFFC can help meet immediate needs when you run short of money. Check out the details of our Emergency Fund program for families served by the Rochester CF Center. 09/11/2020 - Savara Closing Trial of Molgradex in Treating NTM Lung Infections in CF Patients – With all of the attention given to ...

Sep

Survey Opportunity: COVID-19 Vaccine

Cystic Fibrosis Foundation is seeking input from the CF community regarding the potential COVID-19 vaccine(s). Here is their call for participation. The CF Foundation is committed to advocating for the best care for the CF community throughout the COVID-19 pandemic. Research and development for a COVID-19 vaccine is underway and clinical trials are ongoing. As we get closer to the possibility of a COVID-19 vaccine we are interested in learning more about how people with CF, their families and CF care providers are thinking about potential vaccines. Please take this short, 6 - 8 minute survey to help inform our advocacy and education efforts moving forward. Please complete the survey by Friday, September 25th by clicking on the button below. Take the Survey Please contact communityvoice@cff.org if you have any questions or concerns. Thank you for your time and consideration; we greatly appreciate your input! Best, Mary Dwight Chief Policy and Advocacy Officer